Sign in

CIK 0001549595

  • Large accelerated filer

Nurix Therapeutics, Inc.

Sign in to watch
Ticker
NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Nov 30
Incorporated
DE
Entity type
Operating
EIN
270838048
Phone
+1 415-660-5320
Business address
1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
Former names
Nurix, Inc.
  1. 4 Planned sale Chief Legal Officer sold 5,760 shares at an average $21.43 ($123,459)
  2. 4 Open-market sale Chief Scientific Officer sold 3,408 shares at $20.67 ($70,436)
  3. 4 Open-market sale Chief Legal Officer sold 2,920 shares at $20.67 ($60,350)
  4. 4 Open-market sale Chief Financial Officer sold 2,490 shares at $20.67 ($51,463)
  5. 4 Gift Director gave 54,027 shares (gift)
  6. 4 Planned sale Chief Legal Officer sold 5,760 shares at an average $20.81 ($119,837)
  7. 4 Planned sale Chief Financial Officer sold 20,000 shares at $20.01 ($400,216)
  8. 4 Planned sale Chief Legal Officer sold 1,864 shares at $17.02 ($31,721)
  9. 4 Planned sale Chief Legal Officer sold 1,900 shares at $17.01 ($32,319)
  10. 4 Planned sale Chief Legal Officer sold 400 shares at $17.00 ($6,801)
  11. 4 Planned sale Chief Legal Officer sold 1,596 shares at $17.01 ($27,153)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Planned sale Chief Financial Officer sold 3,499 shares at $12.83 ($44,878)
  19. 4 Open-market sale Chief Financial Officer sold 1,387 shares at $12.04 ($16,703)
  20. 4 Open-market sale Chief Scientific Officer sold 2,007 shares at $12.04 ($24,169)

Page 6 of 14 · 274 filings